Table 4.
Association between COVID-19 vaccine hesitancy or refusal and the demographic variables of the participants. Only significant variables are shown.
| Variables | No/Not Sure | Yes | p-Value |
|---|---|---|---|
| Gender | |||
| Male | 7 (14.6) | 36 (75.0) | 0.008 |
| Female | 12 (48.0) | 12 (48.0) | |
| SSA region of origin | |||
| Central Africa | 2 (28.6) | 5 (71.4) | 0.045 |
| East Africa | 2 (40.0) | 3 (60.0) | |
| Southern Africa | 5 (16.7) | 25 (83.3) | |
| West Africa | 10 (32.3) | 15 (48.4) | |
| Place of residence | |||
| Diaspora | 3 (33.3) | 3 (33.3) | 0.009 |
| Local | 15 (24.2) | 44 (71.0) | |
| Have you been tested for COVID-19? | 7 (20.6) | 26 (76.5) | 0.006 |
| Are you concerned about the vaccine safety? | 11 (64.7) | 5 (29.4) | <0.001 |
Responses of those who answered ‘no’ or ‘not sure’ corresponding to ‘hesitancy and refusal’ to the question, ‘will you be willing to receive COVID-19 vaccine when it becomes available in your country?’ were merged. p-value are results of chi-squared analysis.